| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |